Independent lineages of highly sulfadoxine-resistant Plasmodium falciparum haplotypes, Eastern Africa

Emerging Infectious Diseases

Volumn 20, Issue 7, 2014, Pages 1140-1148

  Taylor, Steve M ^a,b   Antonia, Alejandro L ^b,k   Harrington, Whitney E ^c   Goheen, Morgan M ^b   Mwapasa, Victor ^d   Chaluluka, Ebbie ^d   Fried, Michal ^e   Kabyemela, Edward ^f   Madanitsa, Mwayi ^d   Khairallah, Carole ^g   Kalilani Phiri, Linda ^d   Tshefu, Antoinette K ^h   Rogerson, Stephen J ⁱ   ter Kuile, Feiko O ^g,j   Duffy, Patrick E ^e   Meshnick, Steven R ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MALAWI   (Malawi)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^g LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^h UNIVERSITY OF KINSHASA   (Congo)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j UNIVERSITY OF AMSTERDAM   (Netherlands)

^k DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT; DIHYDROPTEROATE SYNTHASE; MICROSATELLITE DNA; SULFADOXINE;

ARTICLE; CROSS-SECTIONAL STUDY; DNA EXTRACTION; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; GEOGRAPHY; HAPLOTYPE; HUMAN; LONGITUDINAL STUDY; OBSERVATIONAL STUDY; PHYLOGENY; PLASMODIUM FALCIPARUM; REAL TIME POLYMERASE CHAIN REACTION; SULFADOXINE RESISTANT PLASMODIUM FALCIPARUM; AFRICA; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; MALARIA, FALCIPARUM; MALAWI; MUTATION; PARASITOLOGY; PREGNANCY;

AFRICA, EASTERN; ANTIMALARIALS; CROSS-SECTIONAL STUDIES; DIHYDROPTEROATE SYNTHASE; DRUG RESISTANCE; FEMALE; HAPLOTYPES; HUMANS; MALARIA, FALCIPARUM; MALAWI; MICROSATELLITE REPEATS; MUTATION; PLASMODIUM FALCIPARUM; PREGNANCY; SULFADOXINE;

EID: 84902809857     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2007.131720     Document Type: Article

References (37)

1. Sridaran S, McClintock SK, Syphard LM, Herman KM, Barnwell JW, Udhayakumar V. Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations. Malar J. 2010;9:247. http://dx.doi.org/10.1186/1475-2875-9-247
2. Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, et al. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet. 2009;374:1533-42. http://dx.doi.org/10.1016/S0140- 6736(09)61258-7
3. Dicko A, Diallo AI, Tembine I, Dicko Y, Dara N, Sidibe Y, et al. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial. PLoS Med. 2011;8:e1000407. http://dx.doi. org/10.1371/journal.pmed.1000407
4. Konaté AT, Yaro JB, Ouedraogo AZ, Diarra A, Gansane A, Soulama I, et al. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double- blind, placebo-controlled trial. PLoS Med. 2011;8:e1000408. http://dx.doi.org/10.1371/journal.pmed.1000408
5. World Health Organization. WHO policy recommendation on intermittent preventive treatment during infancy with sulfadoxinepyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa 2010 [cited 2014 Apr 11]. http://www.who.int/malaria/ news/WHO_policy_recommendation_IPTi_032010.pdf
6. World Health Organization. WHO policy recommendation: seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa 2012 [cited 2014 Apr 11]. http://www.who.int/ malaria/publications/atoz/who_smc_policy_recommendation/en/
7. World Health Organization. WHO policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP) 2013. [cited 2014 Apr 11]. http://www.who.int/malaria/publications/atoz/Policy_ brief_IPTp-SP_implementation_11april2013.pdf
8. Feng G, Simpson JA, Chaluluka E, Molyneux ME, Rogerson SJ. Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed nets. PLoS ONE. 2010;5:e12012. http://dx.doi.org/10.1371/journal. pone.0012012
9. Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE. Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infect Dis. 2011;53:224-30. http://dx.doi.org/10.1093/cid/cir376
10. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, et al. Molecular markers for failure of sulfadoxinepyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 2002;185:380-8. http://dx.doi. org/10.1086/338566
11. Gosling RD, Gesase S, Mosha JF, Carneiro I, Hashim R, Lemnge M, et al. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2009;374:1521-32. http://dx.doi.org/10.1016/S0140-6736(09)60997-1
12. Harrington WE, Mutabingwa TK, Muehlenbachs A, Sorensen B, Bolla MC, Fried M, et al. Competitive facilitation of drugresistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc Natl Acad Sci U S A. 2009;106:9027-32. http://dx.doi.org/10.1073/pnas.0901415106
13. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature. 2002;418:320-3. http://dx.doi.org/10.1038/ nature00813
14. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science. 2004;305:1124. http://dx.doi.org/10.1126/science.1098876
15. Pearce RJ, Pota H, Evehe MS, Bâ el-H, Mombo-Ngoma G, Malisa AL, et al. Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med. 2009;6:e1000055. http://dx.doi.org/10.1371/journal.pmed.1000055
16. Vinayak S, Alam MT, Mixson-Hayden T, McCollum AM, Sem R, Shah NK, et al. Origin and evolution of sulfadoxine resistant Plasmodium falciparum. PLoS Pathog. 2010;6:e1000830. http:// dx.doi.org/10.1371/journal.ppat.1000830
17. Mita T, Venkatesan M, Ohashi J, Culleton R, Takahashi N, Tsukahara T, et al. Limited geographical origin and global spread of sulfadoxine-resistant dhps alleles in Plasmodium falciparum populations. J Infect Dis. 2011;204:1980-8. http://dx.doi. org/10.1093/infdis/jir664
18. Taylor SM, Antonia AL, Chaluluka E, Mwapasa V, Feng G, Molyneux ME, et al. Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study. Clin Infect Dis. 2012;55:42-50. http://dx.doi.org/10.1093/cid/cis301
19. Taylor SM, Messina JP, Hand CC, Juliano JJ, Muwonga J, Tshefu AK, et al. Molecular malaria epidemiology: mapping and burden estimates for the Democratic Republic of the Congo, 2007. PLoS ONE. 2011;6:e16420. http://dx.doi.org/10.1371/journal. pone.0016420
20. Taylor SM, Antonia AL, Parobek CM, Juliano JJ, Janko M, Emch M, et al. Plasmodium falciparum sulfadoxine resistance is geographically and genetically clustered within the DR Congo. Sci Rep. 2013;3:1165. http://dx.doi.org/10.1038/srep01165
21. Peakall R, Smouse PE. GenAlEx 6.5: genetic analysis in Excel. Population genetic software for teaching and research-an update. Bioinformatics. 2012;28:2537-9. http://dx.doi.org/10.1093/bioinformatics/ bts460
22. Excoffier L, Smouse PE, Quattro JM. Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics. 1992;131:479-91.
23. Nei M, Roychoudhury AK. Sampling variances of heterozygosity and genetic distance. Genetics. 1974;76:379-90.
24. Fluxus Engineering. Phylogenetic network software [cited 2012 Oct 19]. http://www.fluxus-engineering.com/sharenet.htm
25. Bandelt HJ, Forster P, Rohl A. Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol. 1999;16:37-48. http://dx.doi.org/10.1093/oxfordjournals.molbev.a026036
26. Hardy OJ, Vekemans X. SPAGeDi: a versatile computer program to analyse spatial genetic structure at the individual or population levels. Molecular Ecology Notes. 2002;2:618-20. http://dx.doi. org/10.1046/j.1471-8286.2002.00305.x
27. Felsenstein J. PHYLIP-Phylogeny Inference Package (version 3.2). Cladistics. 1989;5:164-6.
28. Mobyle Portal. Institut Pasteur [cited 2013 Aug 27]. http://mobyle. pasteur.fr/cgi-bin/portal.py?#forms:neighbor
29. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics. 2000;155:945-59.
30. Hubisz MJ, Falush D, Stephens M, Pritchard JK. Inferring weak population structure with the assistance of sample group information. Mol Ecol Resour. 2009;9:1322-32. http://dx.doi.org/10.1111/j.1755- 0998.2009.02591.x
31. Evanno G, Regnaut S, Goudet J. Detecting the number of clusters of individuals using the software STRUCTURE: a simulation study. Mol Ecol. 2005;14:2611-20. http://dx.doi.org/10.1111/j.1365- 294X.2005.02553.x
32. Taylor SM, Antonia A, Feng G, Mwapasa V, Chaluluka E, Molyneux M, et al. Adaptive evolution and fixation of drug-resistant Plasmodium falciparum genotypes in pregnancy-associated malaria: 9-year results from the QuEERPAM study. Infect Genet Evol. 2012;12:282-90. http://dx.doi.org/10.1016/j.meegid.2011.11.006
33. Minja DT, Schmiegelow C, Mmbando B, Bostrom S, Oesterholt M, Magistrado P, et al. Plasmodium falciparum mutant haplotype infection during pregnancy associated with reduced birthweight, Tanzania. Emerg Infect Dis. 2013;19:1446-54. http://dx.doi. org/10.3201/eid1909.130133
34. Slatkin M. A measure of population subdivision based on microsatellite allele frequencies. Genetics. 1995;139:457-62.
35. Gutman J, Mwandama D, Wiegand RE, Ali D, Mathanga DP, Skarbinski J. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi. J Infect Dis. 2013;208:907-16. http://dx.doi.org/10.1093/infdis/jit276
36. McCollum AM, Poe AC, Hamel M, Huber C, Zhou Z, Shi YP, et al. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J Infect Dis. 2006;194:189-97. http://dx.doi.org/10.1086/504687
37. Naidoo I, Roper C. Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria. Trends Parasitol. 2013;29:505-15. http://dx.doi.org/10.1016/j.pt.2013.08.002